Liquidia – $53 Million IPO

Washington, DC – August 21, 2018 – Cooley advised the underwriters on Liquidia Technologies’ $53.2 million initial public offering of 4,833,099 shares of common stock, which included 287,644 shares issued upon the underwriters’ partial exercise of their option to purchase additional shares to cover over-allotments. Partners Brent Siler, Brian Leaf and Div Gupta led the Cooley team advising the underwriters. 

Jefferies and Cowen acted as the lead book-running managers for the offering. Needham & Company and Wedbush PacGrow acted as co-managers for the offering.

Liquidia Technologies, which now trades on the Nasdaq Capital Market as “LQDA,” is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.



Related Contacts
Brent Siler Partner, Washington, DC
Brian Leaf Partner, Reston
Div Gupta Partner, New York
Madison Jones Associate, Washington, DC
Donald Shum Associate, New York
Jason Drory Associate, Washington, DC
Natasha Leskovsek Partner, Washington, DC
Phil Mitchell Partner, New York
Bill Christiansen Partner, Seattle
Aaron Nudelman Associate, Seattle
Jeffery Wyzykowski Patent Agent, Washington, DC
Stephanie Gentile Partner, New York
Francis Wheeler Partner, Colorado